Abiopharma

🔍 Gendell David B. (Director)

Company: IES Holdings, Inc. (IESC)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 53 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 70,787.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: Held in Family Trust | shares_owned_after: 40,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: H | nature_of_ownership: Held in IRA | shares_owned_after: 6,000.00

Footnotes:

• F1: Represents Phantom Stock Units ("PSUs") granted pursuant to the IES Holdings, Inc. ("IES") 2006 Equity Incentive Plan, as amended and restated (the "2006 Equity Incentive Plan") upon Mr. Gendell electing to receive PSUs in lieu of common stock or cash for that portion of his retainer. Each unit converts to one share of IES common stock when either (i) Mr. Gendell leaves the board of directors for any reason, or (ii) upon a change of control as defined in the 2006 Equity Incentive Plan.